semaglutide brand name Wegovy for the Treatment of Chronic Weight Management, US Ozempic® (semaglutide) GLP-1 RA for

PlexusDx providers can design a personalized discontinuation plan to minimize this risk

Reducing Appetite GLP-1 also acts on the brain to decrease hunger signals, often leading to reduced calorie intake and potential weight loss

The short circulating half-life ( t 1/2 ) of native GLP-1 (1 minute) makes it unfit as a therapeutic agent, and longer-acting GLP-1RAs with half-lives ranging from 2.5 hours to more than a week have been developed for the treatment of both type 2 diabetes and obesity (Table 1) (18)

[PubMed] [Google Scholar] Laurindo L

When someone needs to stay on a psychiatric medication thats working for their mental health but is causing problematic weight gain, adding a low-dose GLP-1 might allow them to maintain their psychiatric stability while addressing the metabolic consequences